Author: Noticewala, Sonal S.; Ludmir, Ethan B.; Bishop, Andrew J.; Chung, Caroline; Ghia, Amol J.; Grosshans, David; McGovern, Susan; Paulino, Arnold de la Cruz; Wang, Chenyang; Woodhouse, Kristina D.; Yeboa, Debra N.; Prabhu, Sujit S.; Weathers, Shiao-Pei; Das, Prajnan; Koong, Albert C.; McAleer, Mary Frances; Li, Jing
Title: Radiation for Glioblastoma in the Era of COVID-19: Patient Selection and Hypofractionation to Maximize Benefit and Minimize Risk Cord-id: qi43vfit Document date: 2020_5_27
ID: qi43vfit
Snippet: We describe the institutional guidelines of a major tertiary cancer center with regard to using hypofractionated radiation regimens to treat glioblastoma as a measure to minimize exposure to coronavirus disease 2019 (COVID-19) while not sacrificing clinical outcomes. Our guidelines review level one evidence of various hypofractionated regimens, and recommend a multidisciplinary approach while balancing the risk of morbidity and mortality among individuals at high risk for severe illness from COV
Document: We describe the institutional guidelines of a major tertiary cancer center with regard to using hypofractionated radiation regimens to treat glioblastoma as a measure to minimize exposure to coronavirus disease 2019 (COVID-19) while not sacrificing clinical outcomes. Our guidelines review level one evidence of various hypofractionated regimens, and recommend a multidisciplinary approach while balancing the risk of morbidity and mortality among individuals at high risk for severe illness from COVID-19 infection. We also briefly outline strategies our department is taking in mitigating risk among our cancer patients undergoing radiation.
Search related documents:
Co phrase search for related documents- local provider and lung disease: 1
Co phrase search for related documents, hyperlinks ordered by date